Retinoic acids (RA) are vitamin A derivatives essential for normal embryonic development and viability of vertebrates. The RA signal is mediated by two distinct classes of receptors, RA receptors (RARs) and retinoid X receptors (RXRs). The RAR family is composed of three genes: RARa, j?, and y. The expression of RAM gene is spatially and temporally restricted in certain structures in the developing embryo, suggesting that RAW could play specific roles during morphogenesis. Four isoforms of the RAM gene (j31-84) are generated by differential usage of promoters and alternative splicing. It has recently been demonstrated that the RAM2 isoform is dispensable for normal development. To ascertain the function of all RAR/I isoforms in vivo, we have generated a mutation that disrupts all isoforms of the RAW gene in the mouse by gene targeting in embryonic stem cells. Mice homozygous for the mutation are viable and fertile with no externally apparent abnormalities. During development, l/l 1 RAW mutant embryos showed fusion of the ninth and tenth cranial ganglia on both sides of the hindbrain. However, no obvious alterations in the spatial pattern of expression of Hoxb-1, Hoxb-4 and Hoxb-5 were observed in day 9.5 p.c. embryos. The RAR/I null mutation did not alter the pattern or extent of the limb and craniofacial malformations induced by RA excess, suggesting that RARj3 may not be mandatory to mediate the observed teratological effects of RA in these structures. These experiments demonstrate that RAM isoforms are not absolutely required for embryonic development and provide additional support to the concept of functional redundancy among members of the RAR family.
Introduction
Normal morphogenesis of vertebrate embryos is severely affected when physiological levels of retinoic acid (RA) and other natural derivatives of vitamin A are altered during development.
Administration of teratogenic doses of RA to pregnant rodent females leads to craniofacial abnormalities and heart defects, presumably by interfering with normal development of the neural crest cells, and to malformation of the limbs (Kochhar, 1961; Lammer et al., 1985; Rosa et al., 1986) . More recently, it has been shown that RA can respecify vertebral identities ' Present address: Department of Genetics, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. in mice (Kessel and Gruss, 1991; Kessel, 1992) and interfere with the axial specification of ectoderm and mesoderm during gastrulation in Xenopus embryos (Durston et al., 1989; Sive et al., 1990; Ruiz i Altaba and Jessell, 1991) . Likewise, offspring of vitamin A deficient (VAD) rodents display severe abnormalities of the eyes, the heart and its outflow tract, the great vessels, and the respiratory and urogenital tracts (Wilson et al., 1953) . Most deleterious consequences of a VAD diet can be eliminated by administration of exogenous RA. Although these observations demonstrated the need for proper maintenance of retinoid levels to maintain normal embryonic development, the precise physiological roles of endogenous RA in the process of morphogenesis are still unclear.
The discovery of nuclear receptors for RA has significantly improved our understanding of the mechanism of RA signal transduction (Gigubre et al., 1987; , 1987) . It is now known that the RA signal is mediated as well as mice deficient for the individual RARal, by two distinct classes of nuclear receptors, RA receptors RAR/32 and RARy2 isoforms (Li et al., 1993; Lohnes et (RARs) and retinoid X receptors (RXRs). These receptors al., 1993; Lufkin et al., 1993; Mendelsohn et al., 1994~) . belong to the steroid/thyroid hormone nuclear receptor Interestingly, RARal, RAM2 and RARy2 null mutants superfamily and function by directly activating transcripappeared healthy and showed no impediment of growth tion via binding to RA response elements (RAREs) of or development, whereas mutants deficient for all RARa target genes predominantly in the form of RAR/RXR hetor RARy isoforms displayed early postnatal lethality and erodimers (reviewed in Chambon, 1994; Gigubre, 1994;  some abnormalities that include testis degeneration in Mangelsdorf et al., 1994) . A number of RA target genes RARa mutant mice and homeotic transformations in have been identified including Hox genes (Tabin, 1991) , RARy mutant mice. When compound mutations of differcomponents of the RA signaling system such as the cytoent RAR isoforms are generated by selective breeding of plasmic retinoic acid binding protein type II (Giguere et different RAR mutant mice, double RAR mutants are not al., 1990a; Durand et al., 1992) and some of the RAR viable and exhibit numerous developmental defects assoisoforms themselves (de The et al., 1990; Sucov et al., ciated with the VAD syndrome (Lohnes et al., 1994; Leroy et al., 1991; Lehmann et al., 1992) . Hox Mendelsohn et al., 1994b) . These experiments clearly genes are known to play roles in axial patterning, and established that RARs participate actively in the transtheir expression is regulated by RA in vivo (Conlon and duction of the RA signal in vivo but also exposed exten- Rossant, 1992; Kessel, 1992; Marshall et al., 1994; Studer sive functional redundancy and compensatory mechaet al., 1994) .
nisms between members of the RAR family. The RAR family is encoded by three genes designated RARa, /?, and y. Each gene generates multiple isoforms (al and a2, /I1 to 84, and yl and y2) which differ in the N-terminal region of the proteins (reviewed in Chambon, 1994; Gigube, 1994; Mangelsdorf et al., 1994) . Differential usage of promoters in each RAR gene, alternative splicing and initiation of translation at a non-AUG codon are mechanisms by which the multiple RAR isoforms are generated. The amino acid sequences of each RAR isoform in different species are highly conserved, suggesting that each isoform may perform specific functions (Leid et al., 1992) . The expression of the RARa gene is almost ubiquitous (Gigubre et al., 1987; de The et al., 1989; DollC et al., 1990; Ruberte et al., 1991) . In contrast, the expression patterns of the RAR/!I and y genes are spatially and temporally restricted (Dollt et al., 1990; Ruberte et al., 1990 Ruberte et al., , 1993 Mendelsohn et al., 1994a) . The expression pattern of RAM in tracheal, intestinal and genital tract epithelia, developing limbs, as well as in central nervous system led to the suggestion that RAM could play distinct roles in the differentiation of these epithelia, as well as in limb development and in normal neurogenesis (Doll6 et al., 1990; Maden and Holder, 1991; Ruberte et al., 1991) . In addition, teratogenic and transgenic mouse studies led to the proposal that RAR/I could be involved in RA-induced abnormalities (Mendelsohn et al., 1991; Harnish et al., 1992; Soprano et al., 1993) . Finally, based on the observation that the RAW gene is inactivated in epidermoid lung cancer cell lines (Gebert et al., 1991; Houle et al., 1991; Nervi et al., 1991) and that transfection of RAW2 into epidermoid lung cancer cells suppressed tumorigenecity (Houle et al., 1993) it has been suggested that RAW2 could also function as a tumor suppressor gene.
To achieve a complete understanding of the role of each RAR isoform in development and postnatal life, as well as the possible role of all RAR/3 isoforms in RAinduced malformation, we have generated a null mutation for the RAW gene (all isoforms disrupted) in the mouse by gene targeting in embryonic stem cells. Our results indicate that mice homozygous for the RAR/3 mutation are viable and fertile, and exhibit no obvious external and internal abnormalities.
The availability of RAR#? null mutants also allowed us to demonstrate that, contrary to earlier suggestions, RAW is not required to mediate RAinduced limb and crania-facial malformations.
Results

Generation of RAR)null mutant mice
An RARp genomic clone isolated from a genomic DNA library derived from the 129/Sv strain was used to construct the targeting vector. The wild-type RARp locus, targeting vector and targeted allele are shown in Fig. 1 . The strategy was to delete sequences in exon 6, which encodes the first zinc-binding motif required for RAW DNA-binding function. This essential sub-domain is common to all RAW isoforms. The homologous recombination would result in disruption of all isoforms of RAW, producing a null mutation.
Recently, gene targeting by homologous recombination in embryonic stem (ES) cells has been used to generate mice deficient for all isoforms of RARa and RARy The RARp targeting vector was electroporated into Rl ES cells, and colonies were selected using G418 and gancyclovir. ES cell clones that had undergone homologous recombination were identified by Southern blot analysis of genomic DNA from individual clones. From a total of 103 clones, five ES cell clones containing a disrupted RAR/? allele were obtained. By using a neomycin (neo) probe, three of these clones were found to have no additional integration sites (data not shown). One such clone was injected into C57BL6 blastocysts to generate chimeras, and one chimera transmitted the mutation to its off from day 9.5 p.c. embryos was used for genotype by PCR. A fragment of 121 bp generated by primer no. 1 (common primer derived from the 5' region of RAR@ exon 6) and no. 2 (wild-type primer derived from the 3' region of RAM exon 6) indicates the presence of wild-type allele, and a product of 385 bp generated by primer nos. 1 and 3 (knock-out primer derived from Pgk-neo cassette) indicates targeted allele.
spring. Heterozygotes for the disrupted RAW allele were apparently normal and were crossed to generate homozygous mutant mice. Fig. 1B shows a representative Southern blot of offspring from crosses of heterozygous mice.
Use of an XbaI digestion and a 5' flanking probe detected 4.5 kb and 5.4 kb fragments for the wild-type and knockout alleles, respectively. The genotypes of day 9.5 and 10.5 p.c. embryos were determined using PCR with a small amount of yolk sac tissue. A representative PCR analysis is shown in Fig. IC . Numbers indicate offspring from heterozygous intercross. DNA was prepared from tail tips and genotyped by Southern blotting. The relative number of RAW wild-type offspring was arbitrarily assigned a value of 1 .O.
RAR,6 homozygous mice appear normal
Heterozygous (RAW'-) mice were crossed to produce homozygous (RAW-l-) offspring. Table 1 shows the number of each genotype obtained. Of 152 offspring, 42 were homozygous for the disrupted allele (RAW-l-) and 32 were wild-type (RAW"), indicating that the RAR@ null mutation is not lethal during embryogenesis or in postnatal development.
RARg-/-mice appeared indistinguishable from their wild-type or RAW'-littermates based on their external appearance. No RARp-'-mice have died unexpectedly, and numerous RARt?-mice have lived at least 12 months. Both RAM-'-males and females were fertile as demonstrated by the results of crossing of RAM-'-mice with RAW'-mice (Table 2 ). Histological examination of the internal organs (brain, heart, lung, trachea, liver, spleen, kidney and gut) of RAW-I-adult did not reveal any abnormalities. No obvious malformation was found in skeletons of day 18.5 p.c. RAR#V fetuses by whole-mount skeletal analysis. In addition, analysis of serial sections of one day 14.5 p.c. RAM-I-and two day 18.5 p.c. fetuses did not uncover any obvious abnormalities. Furthermore, the apparent normal external phenotype of RAW-I-mice occurred in both 129svlCDl and 129svK57BL6 genetic backgrounds.
RAR,@ mice lack wild-type mRNA
It was important to know whether RAM-/-mutant mice have wild-type RAM transcripts, since RAI$?-/-mutants appeared normal. Northern blot analysis was performed to characterize the transcripts produced by the RAM mutated allele. Total RNA was isolated from day 13.5 p.c. embryos of each genotype. Using a probe of a mouse RARp2 cDNA containing an SstVAlwnI fragment from exon 6 (which encodes the first zinc-binding motif of the DNA-binding domain and is a common region for all RAR#? isoforms), no signal was detected in RAW"-RNA samples while approximately half the amount of transcripts was detected in RAR/Ifl-RNA samples (Fig.  2) . Using a mouse 3' RAM2 cDNA fragment as a probe, a band reduced in both intensity and size was detected in RAW-I-RNA (data not shown). A neomycin probe failed to hybridized to a band of the same size. Therefore, the transcript detected with the 3' RAW2 cDNA probe in RAR&'-tissue likely corresponds to a aberrant transcript in which the neomycin sequence is spliced out and sequences encoding the first zinc-binding motif of the DNA-binding domain are deleted. Such a transcript would produce a non-functional RAR@ protein since this domain is required for the DNA-binding function of RAW.
2.4. The levels of RARal/a2 and RARyl/y2 transcripts are not altered in RARp'-embryos
We investigated the possibility that, in RAW-I-embryos, the loss of RAR/3 may cause overexpression of the other RARs, resulting in the apparent normal phenotype of the RAW-'-animals. RNA samples from day 13.5 p.c. embryos with different genotypes, which had been monitored for RAM mRNA, were used to determine the levels of the RARalla2 and RARylly2 transcripts. As shown in Fig. 2 , similar levels of the RARal/a2 and RARylIy2 transcripts were observed in homozygotes, heterozygotes and wild-type embryos. Thus, there was no apparent elevation of expression of RARalla2 or RARylly2 to compensate for the inactivation of the RAW gene. The RNA samples were also examined for the levels of transcripts of CRABP-II, which is RAinducible and involved in the RA signaling pathway. There was no difference in the levels of CRABP-II transcripts between wild-type and the RAR#? mutant embryos (data not shown).
2.5, Hox gene expression is not altered in RAR,&-mice
To determine if the lack of RARB leads to alterations in Hox gene expression, mutant embryos were examined for spatial expression of several Hox genes by in situ hybridization. We chose to look at genes whose anterior boundaries of expression lie within the hindbrain close to, and at, the anterior limit of RARfl expression (Hoxb-1 is expressed in rhombomere 4, Hoxb-4 at the anterior boundary between rhombomeres 6 and 7, Hoxb-5 at the anterior boundary between hindbrain (rhombomere 8) and spinal cord, and RAR,8 at the anterior boundary between rhombomeres 6 and 7). No alterations in the spatial pattern of expression of Hoxb-1, Hoxb-4 and Hoxb-5 were seen in day 9.5 embryos (Fig. 3A and data not shown). Table 2 Fertility of RAR@ mutant mice for neurofilament protein, and examined for alterations in the arrangement of ganglia and nerve tracts. In 10 homozygous mutant embryos, no alterations in the pattern of neurofilament staining was observed. One RAR#?-'-embryo, however, showed fusion of the ninth and tenth cranial ganglia on both sides of the hindbrain (Fig. 3B,C) .
RARP
RARyl
RARy2
PActin RARal RARal I a2 PActin Fig. 2 . Northern blot analysis of total RNA isolated from day 13.5 p,c. wild-type, heterozygous, and homozygous embryos. Twenty micrograms of total RNA were used in each lane. RAR@ mRNA was detected using a mouse RAM cDNA probe containing an SstVAlwnI fragment from exon 6. RARal mRNA was detected using a probe derived from the RARal-specific amino-terminal region. An RARal probe derived from 3' untranslated region common to both RARal and RARa2 transcripts was used to detect RARal and RARa2 mRNA. RARyl and RARy2 transcripts were detected using RARyl-and RARyZ-specific probes respectively. A mousej3actin cDNA probe was used as a loading control.
Fusion of the ninth and tenth cranial ganglia in one RARFI-embryo
The highly regular arrangement of embryonic cranial and spinal ganglia provides landmarks along the axis of the embryo suitable for the detection of subtle abnormalities in embryonic patterning. Accordingly, day 10.5 embryos (2 RAW +'+, 5 RAW'-, 11 RAR/?-) were stained 2.7. RARB is not necessary to mediate the teratogenic effects of retinoid acid on the skull and the limbs It has been shown that exposure to RA at day 8.5 p.c. can cause craniofacial malformation, spina bifida with complete truncation of the caudal axial skeleton and other malformations in the mouse. Also, exposure to RA at day 11.5 p.c. can result in limb malformations.
To determine whether RAR@ is involved in these RA-induced malformations, we treated pregnant female mice from RAR/3+'-crosses with all-trans RA at a concentration of 100 mg/kg at day 8.5 p.c. or 80 mg/kg at day 11.5 p.c. by gastric gavage. Fetuses were collected at day 18.5 p.c. and whole-mount skeletal analysis was performed. As has been reported, several craniofacial abnormalities (including fusion between basisphenoid and basioccipital bone, lack of tympanic rings and palatal bones) were observed in wild-type embryos exposed to RA at day 8.5 p.c. (compare Fig. 4C with 4A) . The same defects were also observed in RA-treated RAR#Y embryos in similar patterns and extent (compare Fig. 4D with 4B and 4C) . RA treatment at day 11.5 p.c. resulted in limb malformation including truncation of long bones and missing digits in both wild-type and RAM-I-embryos (Fig. 5) . RAR#P'-embryos did not show any apparent difference in fashion or extent of limb malformation as compared to wild-type embryos. Fig. 5 shows only the malformation in forelimbs. Similar defects were also observed in hindlimbs from wild-type and mutant embryos exposed to RA at day 11.5 p.c. (data not shown). Thus, RAR/3 is not mandatory to mediate the teratogenic effects of RA in the skull and limbs.
Discussion
We have generated RAW-/-(all isoforms) mice that are viable, fertile and display no obvious defects, indicating that the RAR/? gene is not essential for normal development and general fitness. This result is unexpected to some extent for three reasons. First, the specific expression pattern of the RAR@ gene suggests that it plays important and distinct roles in mouse development (Doll6 et al., 1989 (Doll6 et al., , 1990 Ruberte et al., 1991 Ruberte et al., , 1993 Mendelsohn et al., 1992) ; second, the specific spatial and temporal expression of an RARE-hsp$galactosidase transgene during mouse embryogenesis was previously shown to mimic closely the expression of the RAR/3 gene, thus suggesting that RAR@ might be an essential mediator of RA-induced transcriptional activity during morphogenesis (Rossant et al., 1991) ; and third, the phenotypes of both RARa and RARy total knockout mice were not as severe as expected L&in et al., 1993) . For these reasons, it was anticipated that RAW could act as a major determinant of retinoid signaling during embryogenesis. However, the results of this and other knock-out experiments clearly demonstrate that none of the individual RAR genes plays a dominant role in developmental processes.
Interestingly, combinations of individual RAR isoform disruptions generated from different genes produce some severe malformations and cause the death of newborn pups shortly after birth, although single isoform mutant mice show no apparent defects (Li et al., 1993; Lufkin et al., 1993; Lohnes et al., 1994; Mendelsohn et al., 1994b,c) . These results demonstrate that functional redundancy exists in the RAR family in mice targeted for individual RAR gene, a phenomenon that can considerably confuse interpretation of RAR gene disruption experiments in mice and thus prevent the assignment of specific functions to each RAR gene. However, observations made with doubly disrupted strains suggest that not all RAR isoforms are functionally equivalent since the defects inventoried in double knockout mice (two isoforms in different RAR genes) are more severe than those seen in mice carrying a single RAR gene knockout (mutation of all isoforms in a given RAR gene). It has been shown that RARal expression coexists with RAW expression , therefore RARal could be a candidate to take over the function of RAM in its absence. This possibility has been further strengthened by our recent experiments in which both RARal and RAR/3 genes have been mutated. The RAw6-I-a1-/-mutant mice exhibit severe malformations and die within 30 min after birth (Luo, Sucov, Evans and Gigu&re, manuscript in preparation). The results from this double knockout experiment also confirm that our RAR&'-mutant mice are truly null.
We observed that the patterns of Hoxb-I, Hoxb4, Hoxb-5 and the levels of RARaUa2, RARyl/y2 and C&UP-II transcripts were not altered in the RAR/3 null mutants compared to wild-type animals. Hoxb-I, RARa2, RARy2 and CRABP-II genes have been shown to possess RARE(s) that are critical for RA-responsiveness (Leroy et al., 1991; Durand et al., 1992; Lehmann et aI., 1992; Marshall et al., 1994; Studer et al., 1994; Ogura and Evans, 1995a,b) . Our results suggest that RAW is not mandatory in mediating RA response in those genes. Other RARs could substitute for RAR#? despite the lack of increased expression. The functional compensation of other RAR isoforms in the apparent absence of their induction seems to be a general phenomenon within the RAR family. In the RARal and RARa (all isoforms) null mutants, the mRNA levels of all other RAR isoforms including the RA-responsive /32 and y2 isoforms were not altered (Li et al., 1993; Lufkin et al., 1993) . Similar results were observed in RARy2 and RARr (all isoforms) mutants in which the levels of RA-inducible a2 and /?2 transcripts were not altered . This suggests that in the case of loss of one RAR isoform or all isoforms in a RAR gene, other FUR isoforms are still not ligandsaturated.
We observed that one RAM mutant embryo showed fusion of the ninth and tenth cranial ganglia on both sides of the hindbrain. Although this defect was seen in only Fig. 4 . RA-induced cranial abnormalities in wild-type and RAR@ mutant fetuses. Pregnant females were treated with all-truns RA (100 mg/kg) at day 8.5 p.c. by gastric gavage. Fetuses were collected at day 18.5 p.c. and stained with al&n blue and al&in red. Skulls from untreated wild-type fetus (A) and RAI+!? mutant fetus (B). Skulls from RA-treated wild-type fetus (C) and RAR@ mutant fetus (D). In C and D, the long arrows point to the fusion between basisphenoid (bs) and basioccipital bone (bo). The short arrows point to the lack of tympanic rings and the arrowheads to the lack of palatal bones. Note that both the RA-treated wild-type and RA-treated RAR/J-'-mutant showed similar cranial abnormalities. one RAW-l-embryo out of eleven, this defect was not seen in a total of over 100 wild-type embryos examined in the course of other experiments (R. Conlon and J. Rossant, unpublished observations). The ninth and tenth cranial nerves have their motor roots in rhombomeres 6 and 7 respectively (Lumsden and Keynes, 1989) , on either side of the normal boundary of RAW expression. Thus, the loss of RAM function might lead to localized disruption of patterning in this region of the hindbrain at a low frequency, and further examination of mutant embryos and adults may reveal more subtle defects.
It has been well documented that RA excess could cause a series of congenital malformations that include craniofacial, vertebrae, and limb deformations. Changes of expression patterns of RA-responsive genes, including Hox and RAR genes, are believed to be involved in RAinduced teratogenesis (Kessel and Gruss, 1991; Conlon and Rossant, 1992; Kessel, 1992; Jiang et al., 1994) . RARy gene knockout studies showed that RA-induced lumbosacral truncations were mediated by RARy since RARy-I-embryos were resistant to posterior truncations . However, RARr was not involved in RA-induced craniofacial malformations.
In addition, it has been reported that administration of exogenous RA could induce overexpression and/or ectopic expression of RAW in the craniofacial region and the limbs (Mendelsohn et al., 1991; Rowe et al., 1991; OsumiYamashita et al., 1992) and it has been suggested that RAR/? may mediate the teratogenic effects of RA in these regions (Jiang et al., 1994) . We tested this possibility by exposing pregnant females to teratogenic doses of RA. Our results showed that craniofacial abnormalities (including fusion between basisphenoid and basioccipital bone, lack of tympanic rings and palatal bones) were seen in both wild-type and RAW-/-embryos exposed to RA at day 8.5 p.c., indicating that the presence of RAM is not required for the RA-induced malformations in the craniofacial region. Likewise, there were no apparent differences in pattern or extent of RA-induced limb malformations (including reduced digit numbers and truncation of the radius and ulna) between wild-type and RAR&-embryos. Thus, our results indicate that RAR/? is not necessary to mediate the teratogenic effects of RA on the skull and the limbs. It is possible that RARa may mediate these teratogenic effects, or that the concomitant activation of more than one RAR isoform (from distinct RAR genes) is necessary to generate these effects. We have begun a study of RARalfRAR@ double knockout mice to test these possibilities.
Our work presented here unequivocally demonstrates that the RAR@ gene is dispensable for normal embryonic development and postnatal life, and lends further support to the concept of functional redundancy among members of the RAR family. In view of its proposed role in tumorigenesis, the RAM null mutant mice would be very useful to develop mouse models to investigate the effects of the loss of the RARp gene in the initiation and progression of cancer. Furthermore, the RAR/?'-mice are being used to investigate the interactions of RAW with other members of the RAR and RXR families in double mutant mice.
Materials and methods
Construction of targeting vector
To construct a vector for targeting of the RAR/3 gene (see Fig. l ), a genomic library from a 1291s~ mouse strain was screened with a mouse RAW cDNA fragment encoding the DNA-binding domain of the receptor. A 15 kb RAR/? genomic clone was isolated, which contains exon 6, as demonstrated by restriction enzyme mapping and sequencing data. The targeting vector for the RAR/3 gene was constructed as follows. A 2.0 kb blunted SstI fragment was inserted into the end-filled XhoI site of plasmid pNT and a 7.5 kb XbaYBamHI fragment was cloned into the XbaI/BamHI sites to form the RAW targeting vector. The 0.9 kb SstYXbaI fragment which contains partial exon 6 sequences encoding the first zincbinding motif of the RARp DNA-binding domain, is thus replaced by the neo cassette.
Gene targeting in ES cells and generation of chimeras
The targeting vector was electroporated into RI ES cells using a Bio-Rad gene pulser. Cells were selected with G418 (150yg/ml effective concentration) and gancyclovir (2pM) for 8-10 days. Resistant ES clones were picked and expanded. DNA prepared from these clones was checked by genomic Southern blot analysis for homologous recombination events. Cells from targeted lines were introduced into C57BL/6 blastocysts by microinjection to generate chimeric mice according to published protocols.
Genotyping
Tail and placenta DNAs were genotyped by genomic Southern blot analysis, using a 0.3 kb Asp718/EcoRI fragment as a probe, which is located on genomic DNA upstream of the left arm of the vector (5' flanking probe, Fig. 1 ). Yolk sac DNA was genotyped by PCR. Yolk sac tissue was digested with proteinase K (lOOpg/ml) at 50°C overnight in 100~1 of buffer containing 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2 mM MgC12, 0.1 mg/ml gelatin, 0.45% Nonidet P-40 and 0.45% Tween-20. The proteinase K was inactivated at 94°C for 10 min. Then 2,ul of the digested mixture was used for PCR analysis. PCR was carried out in a Perkin Elmer Cetus Thermal Cycler in a 20~1 final volume for 35 cycles. Each cycle consists of: 94°C for 40 s; 62°C for 1 min; and 72'C for 1 min. Reaction mixtures contained 200pM of each dNTP, 100 ng of each primers, 1 unit of Taq polymerase (Perkin Elmer Cetus), and 1 X PCR buffer (Cetus). PCR reaction (10~1) was resolved on 1.4% agarose gel and stained with ethidium bromide to visualize the amplified fragments. Three primers were used together to identify the RAR/? wild-type allele and RAR@ homologous recombinant allele. Primer no. 1 5'-GTAGCCATCGAGACACAG-AGT-3' (located in the 5' region of RAM exon 6 and containing 4 nucleotides of adjacent intron) was used as a common primer to amplify both wild-type and knock-out alleles. Primer no. 2 S'-TGGTAGCCCGATGACTTG-TCC-3' (located in the 3' region of RAR/? exon 6, which would be deleted in the knock-out allele) and primer no. 3 5'-CCTCTGAGCCCAGAAAGCGAA-3' (located in the Pgk promoter region in the Pgk-neo cassette (Boer et al., 1990) ) were used to amplify the RAR#I wild-type allele and the knock-out allele, respectively. Primer nos. 1 and 2 produced a 121 bp PCR product (wild-type) whereas primer nos. 1 and 3 produced a 385 bp PCR product (knock-out). Although primer nos. 1 and 3 could also amplify any random integration sites, the possibility of random integration events in our RAR#l knock-out line has been ruled out by the results of Southern analyses using both external and internal probes.
Northern analysis
Total RNA was prepared from day 13.5 p.c. RAIQ3 wild-type, heterozygous, and homozygous embryos by the single-step guanidinium-isothiocyanate-phenol technique (Chomczynski and Sacchi, 1987) . Total RNA (20~1) per lane were used for Northern analysis. The RNA samples were separated on 2.2 M formaldehyde/l% agarose gels, transferred to N-Hybond membranes in 20x SSC, and fixed by UV cross-linking.
Hybridization was carried out at 65°C for 2 h in Rapid-hyb buffer (Amersham Life Science), followed by three washes with a final wash in 0.1 X SSUO. 1% SDS at 65°C. The probes used are described in the following. A mouse RAW2 cDNA probe containing a 98 bp SstI/AlwnI fragment in exon 6 common to all RAR/3 isoforms was used to detect RAW mRNAs. A 116 bp HphUAsp7 18 fragment excised from RARal-specific amino-terminal region was used as probe to detect RARal mRNA. An RARal 1.3 kb Asp7 1 UEcoRI fragment derived from 3' untranslated region common to both RARal and RARa2 transcripts was used to detect RARal and RARa2 mRNAs. The probes specific for RARyl and y2 were an EcoRIIAsp718 476 bp fragment and an EcoRI/Asp7 18 262 bp fragment respectively, derived from their respective cDNA clones (Giguere et al., 1990b) . A mouse p-actin cDNA probe was used as a loading control.
Whole mount immunocytochemistry and in situ hybridization
Whole mount in situ hybridization was performed with probes to Hoxb-I (3 RAW/+, 2 RARP+I-and 3 RARp"-), Hoxb-4 (3 RAW'+, 3 RAR/?+I-and 3 RAW-I-) and Hoxb-5 (2 RAW'+, 2 RAW'-and 3 RAW-'-) as de-scribed previously (Conlon and Rossant, 1992) Whole mount immunocytochemistry was performed exactly as described (Davis et al., 1991) , except that the embryos were fixed in 4% paraformaldehyde in PBS for 2 h. The monoclonal antibody 2H3 against the 160 X lo3 M, neurofilament protein (obtained from the Developmental Studies Hybridoma Bank,' University of Iowa) was used at a 1:4 dilution. Peroxidase-coupled goat anti-mouse IgG (Boehringer Mannheim) was used as the secondary antibody at a 1500 dilution.
Skeletal staining and RA treatment
For skeletal analysis, embryos were eviscerated, fixed in 95% ethanol, stained with alcian blue and alizarin red, cleared with 1% KOH and 20% glycerol and the skeletons were stored in 50% ethanol and 50% glycerol as described (Fawcett et al., 1995) . RA treatment was performed by giving all-trans RA to pregnant mice using oral gavage. A dose of 100 mg/kg body weight was given at day 8.5 p.c. to produce craniofacial malformations, while a dose of 80 mg/kg body weight was given at day 11.5 p.c. to generate limb deformities.
